US 11,912,682 B2
Isoindolinone compounds
Bernhard Fasching, Basel (CH); Thomas Ryckmans, Basel (CH); and Alexander Flohr, Basel (CH)
Assigned to Monte Rosa Therapeutics, Inc., Boston, MA (US)
Filed by Monte Rosa Therapeutics, Inc., Boston, MA (US)
Filed on Jul. 10, 2023, as Appl. No. 18/349,634.
Application 18/349,634 is a continuation of application No. PCT/EP2022/050699, filed on Jan. 13, 2022.
Claims priority of provisional application 63/281,049, filed on Nov. 18, 2021.
Prior Publication US 2023/0348418 A1, Nov. 2, 2023
Int. Cl. C07D 401/04 (2006.01)
CPC C07D 401/04 (2013.01) 7 Claims
 
1. A compound represented by the formula:

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt or stereoisomer thereof.